Hamps Bio Limited (BOM:544312)

Market Cap	162.09M
Revenue (ttm)	66.69M
Net Income (ttm)	2.98M
Shares Out	4.36M
EPS (ttm)	0.68
PE Ratio	54.72
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,000
Average Volume	6,400
Open	35.60
Previous Close	37.23
Day's Range	34.21 - 36.30
52-Week Range	36.30 - 107.20
Beta	n/a
RSI	39.72
Earnings Date	Jul 4, 2025

About Hamps Bio

Hamps Bio Limited provides pharmaceutical formulation, and freeze dried and frozen products in India and internationally. The company offers pharmaceutical products that are used as nutrition supplement, injections, pediatric care, toothpaste, mouth wash, antiacid/PPI, painkiller/anti-inflammatory, hematantic/calcium supplement, and anti-biotic/anti-bacterial/anti-fungal. It also offers dry freeze food products comprising of ready to eat foods, juices, ice cream powder, smoothie, tea, fruit snacks, milk related, and other dry food products. Ham...

• Industry: Pharmaceutical Preparations
• Founded: 2007
• Employees: 73
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544312

Financial Performance

In 2024, Hamps Bio's revenue was 66.69 million, an increase of 2.99% compared to the previous year's 64.75 million. Earnings were 2.98 million, a decrease of -40.54%.